Categories AlphaGraphs, Earnings, Health Care
ABT Earnings: Key numbers from Abbott Laboratories Q4 financial results
Abbott (NYSE: ABT) today announced its fourth-quarter financial results for the period ended December 31, 2020.
Net earnings for the fourth quarter was $2.16 billion, or $1.20 per share, compared to net earnings of $1.04 billion, or $0.59 per share in the fourth quarter of 2019.
Total net sales increased 28.7% to $10.7 billion.
Abbott shares inched up 1% during the pre-market hours following the earnings announcement.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
What to expect when J.M. Smucker (SJM) reports Q2 2025 earnings results
Shares of The J.M. Smucker Co. (NYSE: SJM) stayed red on Friday. The stock has dropped 6% over the past three months. The branded foods company is slated to report
Earnings Summary: Highlights of BJ’s Wholesale Club’s Q3 2024 results
Department store chain BJ’s Wholesale Club Holdings, Inc. (NYSE: BJ) has reported financial results for the third quarter of 2024, reporting a 3% increase in net sales. Adjusted earnings, on a
